Patient experience with NOAC therapy, a real life population study
- Universiteit Rijksuniversiteit Groningen
- Promovendus Darko Mitrovic
- Promoters Eric van Roon
- Co-Promoters ds Nic Veeger Karina Meijer
- Jaar 2019 - 2024
Ontwikkeling therapietrouw en PK gedreven interventies bij patiënten met long- of niertransplantatie.
Ontwikkelen van analytische tools om therapietrouw te monitoren.
New medicines are evaluated by registration authorities in order to assess their benefit-risk-balance. However, not every new medicine has to have an added therapeutic value compared to already available medicines. The real clinical relevance of new medicine is therefore sometimes unclear. In this research project, we want to investigate the views of healthcare professionals (HCPs) on clinical relevance of new medicines in primary care. We will discuss healthcare professionals’ views on clinical relevance of new COPD and T2DM medicines and also describe the reasons for prescribing new medicines, which is often not in line with guideline recommendations. Finally, we want to investigate how healthcare professionals assess the clinical relevance of medicines that obtained market access in the last years, and to investigate which pharmaceutical gaps (in other words: which diseases cannot be properly treated and would demand new therapies) HCPs identify in their daily practice.
Onderzoek in Spanje
Dit onderzoek richt zich op de kwaliteit en effectiviteit van zorg door de apotheker bij longaandoeningen. Het goed gebruik van inhalatiemedicatie kent eigen uitdagingen en barrières. Apothekers kunnen hierin een belangrijke rol spelen. Hun handelen kan met behulp van indicatoren inzichtelijk gemaakt worden. Dit onderzoek wil hieraan een bijdrage gaan leveren.